GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Asston Pharmaceuticals Ltd

Asston Pharmaceuticals Approves Preferential Issue of Rs. 27.72 Crore Equity

FUNDRAISE ▲ Positive Development MEDIUM RISK
📅 Filed on BSE: 02 Jul 2026, 06:26 PM IST  ·  BSE ID: f68e5ca1-744b-4cf3-8e7d-fb53712787e0
View Original BSE Filing (PDF)
💡
In Simple Terms
The company is raising money by selling new shares to specific investors at a set price.
🤖 AI Summary
  • Asston Pharmaceuticals to raise Rs. 27,71,99,565 via preferential issue.
  • 24,10,431 equity shares to be issued at Rs. 115 per share.
  • Issue is for persons belonging to the Non-Promoter category.
  • Shareholder approval sought at EGM on July 31, 2026.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Number of Equity Shares to be Issued
24,10,431
Issue Price per Equity Share
Rs. 115/-
Face Value per Equity Share
Rs. 10/-
Premium per Equity Share
Rs. 105/-
Aggregate Amount of Preferential Issue
Rs. 27,71,99,565/-
Date of Board Meeting
July 02, 2026
Date of EGM
July 31, 2026
🏢 How This Affects the Company
💰
Financial Impact
The preferential issue will infuse Rs. 27,71,99,565 in cash into the company, strengthening its balance sheet and providing funds for future operations or expansion.
⚠️
Risk Impact
Execution of the preferential issue is subject to shareholder and regulatory approvals, introducing a compliance risk until completed.
👥 What This Means For Shareholders
✅
Action Required
Shareholders should attend the Extraordinary General Meeting on July 31, 2026, to vote on the preferential issue proposal.
👤
Who Is Affected
Existing shareholders will experience dilution as 24,10,431 new equity shares are issued, impacting their percentage of ownership.
🔍
Management Signal
The decision signals management's intent to raise capital through equity issuance to fund corporate objectives.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Outcome of the EGM on July 31, 2026, for preferential issue approval.
Completion of the preferential share allotment process.
Disclosure of utilization of funds raised from the issue.
MEDIUM RISK Fundraising success is contingent on shareholder and regulatory approvals.
💡 Investor Takeaway
Asston Pharmaceuticals Board approved a Rs. 27,71,99,565 preferential issue of 24,10,431 equity shares at Rs. 115 each to non-promoters.
⚖️ Strengths & Concerns

✅ Positives

  • Fundraising of Rs. 27,71,99,565 at a Rs. 115 issue price, indicating investor confidence.
  • Clear identification of non-promoter category for allotment, suggesting a defined investor base.
❓ Frequently Asked Questions
What is Asston Pharmaceuticals' plan for a preferential issue?
The company plans to issue 24,10,431 equity shares at Rs. 115 each, aggregating Rs. 27,71,99,565/- to non-promoters.
What is the total amount Asston Pharmaceuticals aims to raise through the preferential issue?
Asston Pharmaceuticals aims to raise Rs. 27,71,99,565/- through the preferential issue.
When will shareholders vote on Asston Pharmaceuticals' preferential issue proposal?
Shareholders will vote at an Extraordinary General Meeting scheduled for Friday, July 31, 2026, at 12:30 PM.
What is the issue price and face value for the preferential shares of Asston Pharmaceuticals?
The issue price is Rs. 115/- per share with a face value of Rs. 10/- per share, including a premium of Rs. 105/-.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.